Cargando…
Does VEGF polymorphism play a role in the treatment success with VEGF inhibitors in patients with CNV?
Autores principales: | , , , , , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3016549/ http://dx.doi.org/10.1186/1471-2210-10-S1-A38 |
_version_ | 1782195770025312256 |
---|---|
author | Boltz, Agnes Weigert, Günther Palkovits, Stefan Ruiß, Manuel Weger, Martin El-Shabrawi, Yosuf Garhöfer, Gerhard Jonas, Jost Schmetterer, Leopold |
author_facet | Boltz, Agnes Weigert, Günther Palkovits, Stefan Ruiß, Manuel Weger, Martin El-Shabrawi, Yosuf Garhöfer, Gerhard Jonas, Jost Schmetterer, Leopold |
author_sort | Boltz, Agnes |
collection | PubMed |
description | |
format | Text |
id | pubmed-3016549 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2010 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-30165492011-01-07 Does VEGF polymorphism play a role in the treatment success with VEGF inhibitors in patients with CNV? Boltz, Agnes Weigert, Günther Palkovits, Stefan Ruiß, Manuel Weger, Martin El-Shabrawi, Yosuf Garhöfer, Gerhard Jonas, Jost Schmetterer, Leopold BMC Pharmacol Meeting Abstract BioMed Central 2010-11-16 /pmc/articles/PMC3016549/ http://dx.doi.org/10.1186/1471-2210-10-S1-A38 Text en Copyright ©2010 Boltz et al; licensee BioMed Central Ltd. |
spellingShingle | Meeting Abstract Boltz, Agnes Weigert, Günther Palkovits, Stefan Ruiß, Manuel Weger, Martin El-Shabrawi, Yosuf Garhöfer, Gerhard Jonas, Jost Schmetterer, Leopold Does VEGF polymorphism play a role in the treatment success with VEGF inhibitors in patients with CNV? |
title | Does VEGF polymorphism play a role in the treatment success with VEGF inhibitors in patients with CNV? |
title_full | Does VEGF polymorphism play a role in the treatment success with VEGF inhibitors in patients with CNV? |
title_fullStr | Does VEGF polymorphism play a role in the treatment success with VEGF inhibitors in patients with CNV? |
title_full_unstemmed | Does VEGF polymorphism play a role in the treatment success with VEGF inhibitors in patients with CNV? |
title_short | Does VEGF polymorphism play a role in the treatment success with VEGF inhibitors in patients with CNV? |
title_sort | does vegf polymorphism play a role in the treatment success with vegf inhibitors in patients with cnv? |
topic | Meeting Abstract |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3016549/ http://dx.doi.org/10.1186/1471-2210-10-S1-A38 |
work_keys_str_mv | AT boltzagnes doesvegfpolymorphismplayaroleinthetreatmentsuccesswithvegfinhibitorsinpatientswithcnv AT weigertgunther doesvegfpolymorphismplayaroleinthetreatmentsuccesswithvegfinhibitorsinpatientswithcnv AT palkovitsstefan doesvegfpolymorphismplayaroleinthetreatmentsuccesswithvegfinhibitorsinpatientswithcnv AT ruißmanuel doesvegfpolymorphismplayaroleinthetreatmentsuccesswithvegfinhibitorsinpatientswithcnv AT wegermartin doesvegfpolymorphismplayaroleinthetreatmentsuccesswithvegfinhibitorsinpatientswithcnv AT elshabrawiyosuf doesvegfpolymorphismplayaroleinthetreatmentsuccesswithvegfinhibitorsinpatientswithcnv AT garhofergerhard doesvegfpolymorphismplayaroleinthetreatmentsuccesswithvegfinhibitorsinpatientswithcnv AT jonasjost doesvegfpolymorphismplayaroleinthetreatmentsuccesswithvegfinhibitorsinpatientswithcnv AT schmettererleopold doesvegfpolymorphismplayaroleinthetreatmentsuccesswithvegfinhibitorsinpatientswithcnv |